David Bomze
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 15
- Cancer Immunotherapy and Biomarkers 8
- Colorectal Cancer Treatments and Studies 3
- CAR-T cell therapy research 3
- Co-authors
- Lukas Flatz (10 shared papers)Omar Hasan Ali (9 shared papers)Yaakov Nahmias (4 shared papers)Tomer Meirson (15 shared papers)Merav Cohen (3 shared papers)Gahl Levy (3 shared papers)Daniel Kitsberg (2 shared papers)Gal Markel (11 shared papers)
- Journals
- Bioinformatics (3 papers)JAMA Network Open (2 papers)European Journal of Cancer (2 papers)JAMA Oncology (2 papers)Bone Marrow Transplantation (2 papers)
- Partner nations
- IsraelSwitzerlandUnited States
In The Last Decade
David Bomze
41 papers receiving 1.8k citations
David Bomze's Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 608
- Immunology 332
- Cancer Research 173
- Hepatology 87
- Aging 19
Countries citing papers authored by David Bomze
This map shows the geographic impact of David Bomze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bomze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bomze more than expected).
Fields of papers citing papers by David Bomze
This network shows the impact of papers produced by David Bomze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bomze. The network helps show where David Bomze may publish in the future.
Co-authors
The 25 scholars most cited alongside David Bomze, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Glycolysis-Mediated Changes in Acetyl-CoA and Histone Acetylation Control the Early Differentiation of Embryonic Stem Cells Hit paper breakdown → | 2015 | 518 |
| 2 | 2018 | 143 | |
| 3 | 2015 | 113 | |
| 4 | 2019 | 98 | |
| 5 | 2021 | 95 | |
| 6 | 2016 | 86 | |
| 7 | 2019 | 76 | |
| 8 | 2020 | 69 | |
| 9 | 2015 | 67 | |
| 10 | 2013 | 47 | |
| 11 | 2020 | 42 | |
| 12 | 2017 | 40 | |
| 13 | 2016 | 40 | |
| 14 | 2020 | 39 | |
| 15 | 2022 | 36 | |
| 16 | 2021 | 26 | |
| 17 | 2021 | 25 | |
| 18 | 2022 | 24 | |
| 19 | 2020 | 24 | |
| 20 | 2019 | 24 |
About David Bomze
David Bomze is a scholar working on Molecular Biology, Oncology, Infectious Diseases, Pulmonary and Respiratory Medicine and Epidemiology, having authored 42 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Acute Myeloid Leukemia Research (3 papers), Drug-Induced Adverse Reactions (3 papers), Colorectal Cancer Treatments and Studies (3 papers), CAR-T cell therapy research (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Oncology (608 citations), Immunology (332 citations), Cancer Research (173 citations), Hepatology (87 citations) and Aging (19 citations). David Bomze has collaborated with scholars based in Israel, Switzerland and United States. Frequent co-authors include Lukas Flatz, Omar Hasan Ali, Yaakov Nahmias, Tomer Meirson, Merav Cohen, Gahl Levy, Daniel Kitsberg, Gal Markel, Shai S. Shen-Orr and Malka Nissim‐Rafinia. Their work appears in journals such as Bioinformatics, JAMA Network Open, European Journal of Cancer, JAMA Oncology and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.